by Larry Yost | Jan 29, 2020 | News
MuReva Phototherapy announces initiation of clinical study in patients with head and neck cancer MuReva Phototherapy has announced that the company has initiated a prospective, multi-center, randomized, double-blind, and placebo controlled pivotal clinical study. This...
by Larry Yost | Jan 24, 2020 | News
MuReva Phototherapy completes NIH Commercialization Accelerator Program MuReva Phototherapy has announced that the company has completed the National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) which is only available for Phase II SBIR &...
by Larry Yost | Jun 15, 2019 | News
MuReva Phototherapy’s CEO included in Crain’s Cleveland Business’ list of “Twenty in their 20s” Vedang Kothari, President and CEO of MuReva Phototherapy, has been named to Crain’s Cleveland Business’ 2019 list of “Twenty...
by Larry Yost | Mar 3, 2019 | News
Crain’s Cleveland Business – Lumitex powers up phototherapy startup MuReva Lumitex spins out a new company, MuReva Phototherapy Inc., based on project initiated by Vedang Kothari, who has been appointed as the new company’s President and CEO. The...
by Larry Yost | Sep 13, 2018 | News
MuReva Phototherapy Awarded Phase II Grant for Photobiomodulation Therapy Device MuReva Phototherapy has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant by the National Institutes of Health (NIH) to continue...
